发明名称 |
Assay for predicting the angiographic response to lipid-lowering therapy in patients |
摘要 |
The present invention relates to an assay for testing the genetic predisposition to respond to lipid-lowering therapy in patients with coronary artery disease (CAD), comprising identifying the presence or absence of a TaqIB restriction site in intron 1 in both alleles of the cholesteryl ester transfer protein (CETP) gene by suitable molecular biological techniques; and correlating the presence of the restriction site on one or both alleles with a high or intermediate, susceptibility for lipid-lowering therapy. The invention further relates to a testkit for performing the assay and to a cholesterol ester transfer protein (CETP) gene marker for identifying individuals that may or may not be susceptible for lipid-lowering therapies. |
申请公布号 |
AU2279199(A) |
申请公布日期 |
1999.07.26 |
申请号 |
AU19990022791 |
申请日期 |
1999.01.06 |
申请人 |
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM |
发明人 |
JAN ALBERT KUIVENHOVEN;JOHANNES JACOBUS PIETER KASTELEIN |
分类号 |
C12N15/09;C12Q1/68 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|